UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long‐term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients

Alimentary pharmacology & therapeutics, 2017-02, Vol.45 (4), p.519-532

2017

Volltextzugriff (PDF)

Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn's disease: Results from CARE

Inflammatory bowel diseases, 2012-01, Vol.18 (1), p.1-9

2012

Volltextzugriff (PDF)

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

Gastroenterology (New York, N.Y. 1943), 2002-02, Vol.122 (2), p.512-530

2002

Volltextzugriff (PDF)

Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study

European journal of gastroenterology & hepatology, 2016-11, Vol.28 (11), p.1320-1328

2016

Volltextzugriff (PDF)

Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County

Gut, 2004-06, Vol.53 (6), p.849-853

2004

Volltextzugriff (PDF)

Risk of haematopoietic cancer in patients with inflammatory bowel disease

Gut, 2005-05, Vol.54 (5), p.617-622

2005

Volltextzugriff (PDF)

Family history as a risk factor for colorectal cancer in inflammatory bowel disease

Gastroenterology (New York, N.Y. 1943), 2001-05, Vol.120 (6), p.1356-1362

2001

Volltextzugriff (PDF)

Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission : A predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials

The American journal of gastroenterology, 2005-08, Vol.100 (8), p.1780-1787

2005

Volltextzugriff (PDF)

Clinical course of colorectal Crohn's disease: A 35-year follow-up study of 507 patients

Gastroenterology (New York, N.Y. 1943), 1998-06, Vol.114 (6), p.1151-1160

1998

Volltextzugriff (PDF)

Clinical trial: the safety and short‐term efficacy of recombinant cholera toxin B subunit in the treatment of active Crohn’s disease

Alimentary pharmacology & therapeutics, 2010-02, Vol.31 (3), p.387-395

2010

Volltextzugriff (PDF)

Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study

Gut, 1998-05, Vol.42 (5), p.711-714

1998

Volltextzugriff (PDF)

Down-regulation of interferon-γ parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease : a 12-month follow-up study

International journal of colorectal disease, 2006-09, Vol.21 (6), p.493-504

2006

Volltextzugriff (PDF)

Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.1102-1111.e2

2012

Volltextzugriff (PDF)

Neoplastic transformation of the pelvic pouch mucosa in patients with ulcerative colitis

Gastroenterology (New York, N.Y. 1943), 1997-05, Vol.112 (5), p.1487-1492

1997

Volltextzugriff (PDF)

Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis

Gastroenterology (New York, N.Y. 1943), 1996-06, Vol.110 (6), p.1713-1718

1996

Volltextzugriff (PDF)

Microscopic colitis: a descriptive clinical cohort study of 795 patients with collagenous and lymphocytic colitis

Scandinavian journal of gastroenterology, 2016-05, Vol.51 (5), p.556-562

2016

Volltextzugriff (PDF)

Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: The first 100 patients treated in Scandinavia

Scandinavian journal of gastroenterology, 2007, Vol.42 (2), p.221-227

2007

Volltextzugriff (PDF)

Pouchitis following pelvic pouch operation for ulcerative colitis : Incidence, cumulative risk, and risk factors

Diseases of the colon & rectum, 1996-09, Vol.39 (9), p.1012-1018

1996

Volltextzugriff (PDF)

Increased risk of cancer in ulcerative colitis: a population-based cohort study

The American journal of gastroenterology, 1999-04, Vol.94 (4), p.1047-1052

1999

Volltextzugriff (PDF)

Incidence of Crohn’s disease in Stockholm County 1955–1989

Gut, 1997-10, Vol.41 (4), p.480-486

1997

Volltextzugriff (PDF)

Low molecular weight heparin as adjuvant therapy in active ulcerative colitis

Alimentary pharmacology & therapeutics, 1999-10, Vol.13 (10), p.1323-1328

1999

Volltextzugriff (PDF)

Chronic colitis is associated with a reduction of mucosal alkaline sphingomyelinase activity

Inflammatory bowel diseases, 2002-07, Vol.8 (4), p.258-263

2002

Volltextzugriff (PDF)

Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study

Gut, 1996-07, Vol.39 (1), p.82-86

1996

Volltextzugriff (PDF)

Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis

European journal of gastroenterology & hepatology, 1998-10, Vol.10 (10), p.831-836

1998

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(98)

Sprache

Englisch
(96)
Schwedisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(98)
Female
(86)
Male
(84)
Life Sciences & Biomedicine
(82)
Science & Technology
(82)
Middle Aged
(78)
Medicin Och Hälsovetenskap
(69)
Gastroenterology & Hepatology
(68)
Biological And Medical Sciences
(53)
Medical Sciences
(52)
Aged
(49)
Adolescent
(41)
Ulcerative Colitis
(30)
Gastroenterology. Liver. Pancreas. Abdomen
(26)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(24)
Treatment Outcome
(23)
Colitis, Ulcerative - Pathology
(21)
Colitis, Ulcerative - Drug Therapy
(20)
Other Diseases. Semiology
(19)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long‐term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients

Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn's disease: Results from CARE

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study

Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County

Risk of haematopoietic cancer in patients with inflammatory bowel disease

Family history as a risk factor for colorectal cancer in inflammatory bowel disease

Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission : A predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials

Clinical course of colorectal Crohn's disease: A 35-year follow-up study of 507 patients

Clinical trial: the safety and short‐term efficacy of recombinant cholera toxin B subunit in the treatment of active Crohn’s disease

Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study

Down-regulation of interferon-γ parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease : a 12-month follow-up study

Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial

Neoplastic transformation of the pelvic pouch mucosa in patients with ulcerative colitis

Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis

Microscopic colitis: a descriptive clinical cohort study of 795 patients with collagenous and lymphocytic colitis

Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: The first 100 patients treated in Scandinavia

Pouchitis following pelvic pouch operation for ulcerative colitis : Incidence, cumulative risk, and risk factors

Increased risk of cancer in ulcerative colitis: a population-based cohort study

Incidence of Crohn’s disease in Stockholm County 1955–1989

Low molecular weight heparin as adjuvant therapy in active ulcerative colitis

Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial

Chronic colitis is associated with a reduction of mucosal alkaline sphingomyelinase activity

Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study

Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis

Aktive Filter

Suchergebnisse filtern